{"id":344736,"date":"2026-11-12T13:18:32","date_gmt":"2026-11-12T07:48:32","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=344736"},"modified":"2026-11-12T13:18:32","modified_gmt":"2026-11-12T07:48:32","slug":"pharma-ingredients-maker-utility-vehicles-maker-and-footwear-retailer-stocks-roadmap-sierra-list","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/pharma-ingredients-maker-utility-vehicles-maker-and-footwear-retailer-stocks-roadmap-sierra-list\/","title":{"rendered":"3 Pharma Ingredients Maker, Utility Vehicles Maker and Footwear Retailer Stocks With a Strong Future Roadmap: Neuland Laboratories, Force Motors and Bata India"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E84;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Neuland Laboratories, Force Motors and Bata India: ROE of 10.4% to 25.2% and FY22 to FY26 revenue CAGR of 10.1% to 29.2%. Prices as of 11 Nov 2026.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E84;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">The three drug ingredient, vehicle and footwear stocks to watch are Neuland Laboratories, Force Motors and Bata India. Their return on equity ranges from 10.4% to 25.2%, and their revenue compound annual growth from FY22 to FY26 ranges from 10.1% to 29.2%. Force Motors leads on both return on equity at 25.2% and revenue growth at 29.2% a year. Prices are based on the 11 November 2026 close, and this article is educational, not investment advice.<\/p>\n<\/div>\n<p>Drug ingredient, vehicle and footwear stocks offer a focused view of a sector where demand keeps widening. Neuland Laboratories, Force Motors and Bata India cover a pharma ingredients maker, a utility vehicles maker and a footwear retailer.<\/p>\n<p>This list covers three drug ingredient, vehicle and footwear stocks with complete current figures: Neuland Laboratories, Force Motors and Bata India. Every figure comes from the latest reported financials and the 11 November 2026 market close. Companies without complete current figures were left out.<\/p>\n<p style=\"margin-top:24px;\"><strong><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=pharma-ingredients-maker-utility-vehicles-maker-and-footwear-retailer-stocks-roadmap-sierra-list\">Click Here &#8211; Get Free Investment Predictions<\/a><\/strong><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/pharma-ingredients-maker-utility-vehicles-maker-and-footwear-retailer-stocks-roadmap-sierra-list\/#What_Are_Drug_Ingredient_Vehicle_and_Footwear_Stocks\" title=\"What Are Drug Ingredient, Vehicle and Footwear Stocks?\">What Are Drug Ingredient, Vehicle and Footwear Stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/pharma-ingredients-maker-utility-vehicles-maker-and-footwear-retailer-stocks-roadmap-sierra-list\/#Drug_Ingredient_Vehicle_and_Footwear_Stocks_at_a_Glance\" title=\"Drug Ingredient, Vehicle and Footwear Stocks at a Glance\">Drug Ingredient, Vehicle and Footwear Stocks at a Glance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/pharma-ingredients-maker-utility-vehicles-maker-and-footwear-retailer-stocks-roadmap-sierra-list\/#Why_Do_Drug_Ingredient_Vehicle_and_Footwear_Stocks_Have_a_Strong_Roadmap_in_India\" title=\"Why Do Drug Ingredient, Vehicle and Footwear Stocks Have a Strong Roadmap in India?\">Why Do Drug Ingredient, Vehicle and Footwear Stocks Have a Strong Roadmap in India?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/pharma-ingredients-maker-utility-vehicles-maker-and-footwear-retailer-stocks-roadmap-sierra-list\/#Why_Neuland_Laboratories_Features_Among_These_Drug_Ingredient_Vehicle_and_Footwear_Stocks\" title=\"Why Neuland Laboratories Features Among These Drug Ingredient, Vehicle and Footwear Stocks\">Why Neuland Laboratories Features Among These Drug Ingredient, Vehicle and Footwear Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/pharma-ingredients-maker-utility-vehicles-maker-and-footwear-retailer-stocks-roadmap-sierra-list\/#Why_Force_Motors_Features_Among_These_Drug_Ingredient_Vehicle_and_Footwear_Stocks\" title=\"Why Force Motors Features Among These Drug Ingredient, Vehicle and Footwear Stocks\">Why Force Motors Features Among These Drug Ingredient, Vehicle and Footwear Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/pharma-ingredients-maker-utility-vehicles-maker-and-footwear-retailer-stocks-roadmap-sierra-list\/#Why_Bata_India_Features_Among_These_Drug_Ingredient_Vehicle_and_Footwear_Stocks\" title=\"Why Bata India Features Among These Drug Ingredient, Vehicle and Footwear Stocks\">Why Bata India Features Among These Drug Ingredient, Vehicle and Footwear Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/pharma-ingredients-maker-utility-vehicles-maker-and-footwear-retailer-stocks-roadmap-sierra-list\/#Neuland_Laboratories_vs_Force_Motors_vs_Bata_India_on_Key_Financials\" title=\"Neuland Laboratories vs Force Motors vs Bata India on Key Financials\">Neuland Laboratories vs Force Motors vs Bata India on Key Financials<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/pharma-ingredients-maker-utility-vehicles-maker-and-footwear-retailer-stocks-roadmap-sierra-list\/#Key_Risks_to_Check_Before_Investing_in_Drug_Ingredient_Vehicle_and_Footwear_Stocks\" title=\"Key Risks to Check Before Investing in Drug Ingredient, Vehicle and Footwear Stocks\">Key Risks to Check Before Investing in Drug Ingredient, Vehicle and Footwear Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/pharma-ingredients-maker-utility-vehicles-maker-and-footwear-retailer-stocks-roadmap-sierra-list\/#Final_Thoughts_on_Drug_Ingredient_Vehicle_and_Footwear_Stocks\" title=\"Final Thoughts on Drug Ingredient, Vehicle and Footwear Stocks\">Final Thoughts on Drug Ingredient, Vehicle and Footwear Stocks<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/pharma-ingredients-maker-utility-vehicles-maker-and-footwear-retailer-stocks-roadmap-sierra-list\/#What_are_drug_ingredient_vehicle_and_footwear_stocks\" title=\"What are drug ingredient, vehicle and footwear stocks?\">What are drug ingredient, vehicle and footwear stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/pharma-ingredients-maker-utility-vehicles-maker-and-footwear-retailer-stocks-roadmap-sierra-list\/#Which_drug_ingredient_vehicle_and_footwear_stocks_are_covered_in_this_list\" title=\"Which drug ingredient, vehicle and footwear stocks are covered in this list?\">Which drug ingredient, vehicle and footwear stocks are covered in this list?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/pharma-ingredients-maker-utility-vehicles-maker-and-footwear-retailer-stocks-roadmap-sierra-list\/#Why_do_drug_ingredient_vehicle_and_footwear_stocks_have_a_strong_future_roadmap_in_India\" title=\"Why do drug ingredient, vehicle and footwear stocks have a strong future roadmap in India?\">Why do drug ingredient, vehicle and footwear stocks have a strong future roadmap in India?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/pharma-ingredients-maker-utility-vehicles-maker-and-footwear-retailer-stocks-roadmap-sierra-list\/#How_has_Neuland_Laboratories_performed_financially\" title=\"How has Neuland Laboratories performed financially?\">How has Neuland Laboratories performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/pharma-ingredients-maker-utility-vehicles-maker-and-footwear-retailer-stocks-roadmap-sierra-list\/#How_has_Force_Motors_performed_financially\" title=\"How has Force Motors performed financially?\">How has Force Motors performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/pharma-ingredients-maker-utility-vehicles-maker-and-footwear-retailer-stocks-roadmap-sierra-list\/#How_has_Bata_India_performed_financially\" title=\"How has Bata India performed financially?\">How has Bata India performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/pharma-ingredients-maker-utility-vehicles-maker-and-footwear-retailer-stocks-roadmap-sierra-list\/#What_risks_should_investors_check_before_buying_drug_ingredient_vehicle_and_footwear_stocks\" title=\"What risks should investors check before buying drug ingredient, vehicle and footwear stocks?\">What risks should investors check before buying drug ingredient, vehicle and footwear stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/pharma-ingredients-maker-utility-vehicles-maker-and-footwear-retailer-stocks-roadmap-sierra-list\/#Is_this_list_of_drug_ingredient_vehicle_and_footwear_stocks_investment_advice\" title=\"Is this list of drug ingredient, vehicle and footwear stocks investment advice?\">Is this list of drug ingredient, vehicle and footwear stocks investment advice?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"What_Are_Drug_Ingredient_Vehicle_and_Footwear_Stocks\"><\/span><strong>What Are Drug Ingredient, Vehicle and Footwear Stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Drug ingredient, vehicle and footwear stocks are listed companies that make active pharmaceutical ingredients and custom molecules for global drug firms, build utility vehicles, vans and engines, and sell branded footwear through stores across many cities. Their earnings depend on drug sourcing, vehicle demand and consumer spending.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Drug_Ingredient_Vehicle_and_Footwear_Stocks_at_a_Glance\"><\/span><strong>Drug Ingredient, Vehicle and Footwear Stocks at a Glance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Company<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">CMP (Rs)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Market Cap (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">P\/E<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Industry P\/E<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">ROE (%)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">D\/E<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/neulandlab\/neuland-laboratories-ltd-share-price-today\">Neuland Laboratories<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">20,204<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">24,665<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">49.5<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">36.0<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">19.4<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.16<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/forcemot\/force-motors-ltd-share-price-today\">Force Motors<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">19,872<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">23,296<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">18.6<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">24.1<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">25.2<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.00<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/bataindia\/bata-india-ltd-share-price-today\">Bata India<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">642.1<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">8,187<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">56.0<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">37.0<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">10.4<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.87<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p>On valuation, Force Motors trades at a P\/E below the industry P\/E, while Neuland Laboratories and Bata India trade above it, which reflects the growth the market already expects. Readers comparing drug ingredient, vehicle and footwear stocks should look at return on equity and debt together, since a high return earned with low debt is easier to sustain.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Do_Drug_Ingredient_Vehicle_and_Footwear_Stocks_Have_a_Strong_Roadmap_in_India\"><\/span><strong>Why Do Drug Ingredient, Vehicle and Footwear Stocks Have a Strong Roadmap in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Drug ingredient, vehicle and footwear stocks have a strong roadmap in India because growing global sourcing of pharma ingredients, steady demand for utility vehicles and rising demand for branded footwear keep widening the market for these companies.<\/p>\n<ul>\n<li><strong>Pharma ingredients.<\/strong> Drug makers need reliable specialty inputs.<\/li>\n<li><strong>Utility vehicles.<\/strong> Fleets and families need versatile vehicles.<\/li>\n<li><strong>Footwear.<\/strong> Shoppers upgrade to branded footwear.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Why_Neuland_Laboratories_Features_Among_These_Drug_Ingredient_Vehicle_and_Footwear_Stocks\"><\/span><strong>Why Neuland Laboratories Features Among These Drug Ingredient, Vehicle and Footwear Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the drug ingredient, vehicle and footwear stocks on this list, Neuland Laboratories, based in Hyderabad, makes active pharmaceutical ingredients for generic drugs and runs a custom manufacturing business that supplies innovator companies.<\/p>\n<p>Revenue rose from Rs 953 crore in FY22 to Rs 2,053 crore in FY26, a compound annual growth rate of 21.1%. Net profit grew from Rs 63.8 crore in FY22 to Rs 364 crore in FY26, which works out to a compound annual growth rate of 54.5%.<\/p>\n<p>The company has a return on equity of 19.4%, a debt to equity ratio of 0.16 and a market capitalisation of Rs 24,665 crore. The stock trades at a P\/E of 49.5, above the industry P\/E of 36.0.<\/p>\n<p><strong>Roadmap:<\/strong> The company is moving up the value chain by growing custom manufacturing, which carries longer contracts and better margins than commodity generic ingredients. A strong order book for development-stage molecules gives visibility on multi-year volumes.<\/p>\n<p><strong>What to watch:<\/strong> Custom manufacturing revenue can move between quarters, so review the full-year trend.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Force_Motors_Features_Among_These_Drug_Ingredient_Vehicle_and_Footwear_Stocks\"><\/span><strong>Why Force Motors Features Among These Drug Ingredient, Vehicle and Footwear Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the API maker, tempo traveller and shoe brand shares on this list, Force Motors, based in Pune, makes light commercial vehicles such as the Traveller and Gurkha, and supplies engines and axles to global carmakers.<\/p>\n<p>The company has a return on equity of 25.2%, a debt to equity ratio of 0.00 and a market capitalisation of Rs 23,296 crore. The stock trades at a P\/E of 18.6, below the industry P\/E of 24.1.<\/p>\n<p>Revenue rose from Rs 3,292 crore in FY22 to Rs 9,168 crore in FY26, a compound annual growth rate of 29.2%. Net profit grew from Rs 801 crore in FY25 to Rs 1,212 crore in FY26, a rise of 51.3%. In the June 2026 quarter, revenue grew 6.7% year on year to Rs 2,478 crore, while net profit rose 22.8% to Rs 217 crore.<\/p>\n<p><strong>Roadmap:<\/strong> Its traveller and ambulance range, defence vehicle supply and contract manufacturing for international partners give it several growth routes. It has no debt on its books, which leaves room for investment in new models.<\/p>\n<p><strong>What to watch:<\/strong> Track order flow from state transport and defence customers.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Bata_India_Features_Among_These_Drug_Ingredient_Vehicle_and_Footwear_Stocks\"><\/span><strong>Why Bata India Features Among These Drug Ingredient, Vehicle and Footwear Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the three companies on this list, Bata India is the country&#8217;s largest footwear retailer, selling under the Bata, Hush Puppies, Power and other brands through a large network of company-owned and franchised stores.<\/p>\n<p>Revenue rose from Rs 2,444 crore in FY22 to Rs 3,595 crore in FY26, a compound annual growth rate of 10.1%. Net profit grew from Rs 103 crore in FY22 to Rs 134 crore in FY26, which works out to a compound annual growth rate of 6.8%.<\/p>\n<p>In the June 2026 quarter, revenue grew 4.0% year on year to Rs 997 crore, while net profit rose 23.0% to Rs 64.0 crore. The company has a return on equity of 10.4%, a debt to equity ratio of 0.87 and a market capitalisation of Rs 8,187 crore. The stock trades at a P\/E of 56.0, above the industry P\/E of 37.0.<\/p>\n<p><strong>Roadmap:<\/strong> The company is widening its range into sports, casual and premium footwear and adding stores in smaller towns. A trusted brand and deep retail reach support steady demand.<\/p>\n<p><strong>What to watch:<\/strong> Follow store additions, premium product mix and same-store sales.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Neuland_Laboratories_vs_Force_Motors_vs_Bata_India_on_Key_Financials\"><\/span><strong>Neuland Laboratories vs Force Motors vs Bata India on Key Financials<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table below sets the three drug ingredient, vehicle and footwear stocks side by side on revenue, profit and margin, using reported figures.<\/p>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Company<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY22 Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Revenue CAGR (FY22-FY26)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Net Profit (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Net Margin<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Neuland Laboratories<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">953<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">2,053<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">21.1%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">364<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">17.7%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Force Motors<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">3,292<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">9,168<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">29.2%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,212<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">13.2%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Bata India<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">2,444<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">3,595<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">10.1%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">134<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">3.7%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p>Force Motors posts the highest return on equity in this group at 25.2%. Force Motors combines the largest FY26 revenue at Rs 9,168 crore with the fastest revenue growth, a 29.2% compound annual rate. A useful habit with drug ingredient, vehicle and footwear stocks is to check each new quarterly result against the capacity plans the company described earlier.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_to_Check_Before_Investing_in_Drug_Ingredient_Vehicle_and_Footwear_Stocks\"><\/span><strong>Key Risks to Check Before Investing in Drug Ingredient, Vehicle and Footwear Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Every theme carries risks that deserve a check before any decision. For these drug ingredient, vehicle and footwear stocks, the main points are:<\/p>\n<ul>\n<li><strong>Regulatory approvals.<\/strong> Plant inspections and approvals can affect supplies.<\/li>\n<li><strong>Production cycles.<\/strong> Vehicle output can vary with demand.<\/li>\n<li><strong>Footfall and spending.<\/strong> Store sales follow consumer mood and seasons.<\/li>\n<\/ul>\n<p>Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.<\/p>\n<p style=\"margin-top:24px;\"><strong><a href=\"https:\/\/univest.in\/screeners\">Use the Univest Stock Screener<\/a><\/strong> to filter drug ingredient, vehicle and footwear stocks by market capitalisation, P\/E, ROE and growth, and build your own shortlist.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Final_Thoughts_on_Drug_Ingredient_Vehicle_and_Footwear_Stocks\"><\/span><strong>Final Thoughts on Drug Ingredient, Vehicle and Footwear Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Drug ingredient, vehicle and footwear stocks reward patient research into demand, execution and financial strength. Neuland Laboratories, Force Motors and Bata India each have a clear plan to grow. Based on the 11 November 2026 close, Neuland Laboratories trades at Rs 20,204, Force Motors at Rs 19,872 and Bata India at Rs 642.1.<\/p>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track drug ingredient, vehicle and footwear stocks, set price alerts and get research-backed stock ideas.<\/em><\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h3><span class=\"ez-toc-section\" id=\"What_are_drug_ingredient_vehicle_and_footwear_stocks\"><\/span><strong>What are drug ingredient, vehicle and footwear stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Drug ingredient, vehicle and footwear stocks are listed companies that make active pharmaceutical ingredients and custom molecules for global drug firms, build utility vehicles, vans and engines, and sell branded footwear through stores across many cities. Their earnings depend on drug sourcing, vehicle demand and consumer spending. This list looks at three of them, Neuland Laboratories, Force Motors and Bata India, using reported FY22 to FY26 financials and the 11 November 2026 closing prices.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_drug_ingredient_vehicle_and_footwear_stocks_are_covered_in_this_list\"><\/span><strong>Which drug ingredient, vehicle and footwear stocks are covered in this list?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> This list covers Neuland Laboratories, Force Motors and Bata India. Based on the 11 November 2026 close, Neuland Laboratories traded at Rs 20,204, Force Motors at Rs 19,872 and Bata India at Rs 642.1. Their return on equity ranges from 10.4% to 25.2%, and their revenue compound annual growth from FY22 to FY26 ranges from 10.1% to 29.2%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_do_drug_ingredient_vehicle_and_footwear_stocks_have_a_strong_future_roadmap_in_India\"><\/span><strong>Why do drug ingredient, vehicle and footwear stocks have a strong future roadmap in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Drug ingredient, vehicle and footwear stocks have a strong roadmap in India because growing global sourcing of pharma ingredients, steady demand for utility vehicles and rising demand for branded footwear keep widening the market for these companies. The main drivers are as follows. Pharma ingredients. Drug makers need reliable specialty inputs. Utility vehicles. Fleets and families need versatile vehicles. Footwear. Shoppers upgrade to branded footwear. Together these factors give the companies on this list a visible path for growth over the coming years.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_Neuland_Laboratories_performed_financially\"><\/span><strong>How has Neuland Laboratories performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 953 crore in FY22 to Rs 2,053 crore in FY26, a compound annual growth rate of 21.1%. Net profit grew from Rs 63.8 crore in FY22 to Rs 364 crore in FY26, which works out to a compound annual growth rate of 54.5%. The company has a return on equity of 19.4%, a debt to equity ratio of 0.16 and a market capitalisation of Rs 24,665 crore. The stock trades at a P\/E of 49.5, above the industry P\/E of 36.0. Looking ahead, the company is moving up the value chain by growing custom manufacturing, which carries longer contracts and better margins than commodity generic ingredients. A strong order book for development-stage molecules gives visibility on multi-year volumes.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_Force_Motors_performed_financially\"><\/span><strong>How has Force Motors performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 3,292 crore in FY22 to Rs 9,168 crore in FY26, a compound annual growth rate of 29.2%. Net profit grew from Rs 801 crore in FY25 to Rs 1,212 crore in FY26, a rise of 51.3%. In the June 2026 quarter, revenue grew 6.7% year on year to Rs 2,478 crore, while net profit rose 22.8% to Rs 217 crore. The company has a return on equity of 25.2%, a debt to equity ratio of 0.00 and a market capitalisation of Rs 23,296 crore. The stock trades at a P\/E of 18.6, below the industry P\/E of 24.1. Looking ahead, its traveller and ambulance range, defence vehicle supply and contract manufacturing for international partners give it several growth routes. It has no debt on its books, which leaves room for investment in new models.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_Bata_India_performed_financially\"><\/span><strong>How has Bata India performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 2,444 crore in FY22 to Rs 3,595 crore in FY26, a compound annual growth rate of 10.1%. Net profit grew from Rs 103 crore in FY22 to Rs 134 crore in FY26, which works out to a compound annual growth rate of 6.8%. In the June 2026 quarter, revenue grew 4.0% year on year to Rs 997 crore, while net profit rose 23.0% to Rs 64.0 crore. The company has a return on equity of 10.4%, a debt to equity ratio of 0.87 and a market capitalisation of Rs 8,187 crore. The stock trades at a P\/E of 56.0, above the industry P\/E of 37.0. Looking ahead, the company is widening its range into sports, casual and premium footwear and adding stores in smaller towns. A trusted brand and deep retail reach support steady demand.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_risks_should_investors_check_before_buying_drug_ingredient_vehicle_and_footwear_stocks\"><\/span><strong>What risks should investors check before buying drug ingredient, vehicle and footwear stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Investors should check a few risks before buying drug ingredient, vehicle and footwear stocks. Regulatory approvals. Plant inspections and approvals can affect supplies. Production cycles. Vehicle output can vary with demand. Footfall and spending. Store sales follow consumer mood and seasons. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_this_list_of_drug_ingredient_vehicle_and_footwear_stocks_investment_advice\"><\/span><strong>Is this list of drug ingredient, vehicle and footwear stocks investment advice?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> No. This article is educational and uses publicly available data as of the 11 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What are drug ingredient, vehicle and footwear stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Drug ingredient, vehicle and footwear stocks are listed companies that make active pharmaceutical ingredients and custom molecules for global drug firms, build utility vehicles, vans and engines, and sell branded footwear through stores across many cities. Their earnings depend on drug sourcing, vehicle demand and consumer spending. This list looks at three of them, Neuland Laboratories, Force Motors and Bata India, using reported FY22 to FY26 financials and the 11 November 2026 closing prices.\"}},{\"@type\":\"Question\",\"name\":\"Which drug ingredient, vehicle and footwear stocks are covered in this list?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"This list covers Neuland Laboratories, Force Motors and Bata India. Based on the 11 November 2026 close, Neuland Laboratories traded at Rs 20,204, Force Motors at Rs 19,872 and Bata India at Rs 642.1. Their return on equity ranges from 10.4% to 25.2%, and their revenue compound annual growth from FY22 to FY26 ranges from 10.1% to 29.2%.\"}},{\"@type\":\"Question\",\"name\":\"Why do drug ingredient, vehicle and footwear stocks have a strong future roadmap in India?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Drug ingredient, vehicle and footwear stocks have a strong roadmap in India because growing global sourcing of pharma ingredients, steady demand for utility vehicles and rising demand for branded footwear keep widening the market for these companies. The main drivers are as follows. Pharma ingredients. Drug makers need reliable specialty inputs. Utility vehicles. Fleets and families need versatile vehicles. Footwear. Shoppers upgrade to branded footwear. Together these factors give the companies on this list a visible path for growth over the coming years.\"}},{\"@type\":\"Question\",\"name\":\"How has Neuland Laboratories performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 953 crore in FY22 to Rs 2,053 crore in FY26, a compound annual growth rate of 21.1%. Net profit grew from Rs 63.8 crore in FY22 to Rs 364 crore in FY26, which works out to a compound annual growth rate of 54.5%. The company has a return on equity of 19.4%, a debt to equity ratio of 0.16 and a market capitalisation of Rs 24,665 crore. The stock trades at a P\/E of 49.5, above the industry P\/E of 36.0. Looking ahead, the company is moving up the value chain by growing custom manufacturing, which carries longer contracts and better margins than commodity generic ingredients. A strong order book for development-stage molecules gives visibility on multi-year volumes.\"}},{\"@type\":\"Question\",\"name\":\"How has Force Motors performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 3,292 crore in FY22 to Rs 9,168 crore in FY26, a compound annual growth rate of 29.2%. Net profit grew from Rs 801 crore in FY25 to Rs 1,212 crore in FY26, a rise of 51.3%. In the June 2026 quarter, revenue grew 6.7% year on year to Rs 2,478 crore, while net profit rose 22.8% to Rs 217 crore. The company has a return on equity of 25.2%, a debt to equity ratio of 0.00 and a market capitalisation of Rs 23,296 crore. The stock trades at a P\/E of 18.6, below the industry P\/E of 24.1. Looking ahead, its traveller and ambulance range, defence vehicle supply and contract manufacturing for international partners give it several growth routes. It has no debt on its books, which leaves room for investment in new models.\"}},{\"@type\":\"Question\",\"name\":\"How has Bata India performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 2,444 crore in FY22 to Rs 3,595 crore in FY26, a compound annual growth rate of 10.1%. Net profit grew from Rs 103 crore in FY22 to Rs 134 crore in FY26, which works out to a compound annual growth rate of 6.8%. In the June 2026 quarter, revenue grew 4.0% year on year to Rs 997 crore, while net profit rose 23.0% to Rs 64.0 crore. The company has a return on equity of 10.4%, a debt to equity ratio of 0.87 and a market capitalisation of Rs 8,187 crore. The stock trades at a P\/E of 56.0, above the industry P\/E of 37.0. Looking ahead, the company is widening its range into sports, casual and premium footwear and adding stores in smaller towns. A trusted brand and deep retail reach support steady demand.\"}},{\"@type\":\"Question\",\"name\":\"What risks should investors check before buying drug ingredient, vehicle and footwear stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Investors should check a few risks before buying drug ingredient, vehicle and footwear stocks. Regulatory approvals. Plant inspections and approvals can affect supplies. Production cycles. Vehicle output can vary with demand. Footfall and spending. Store sales follow consumer mood and seasons. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.\"}},{\"@type\":\"Question\",\"name\":\"Is this list of drug ingredient, vehicle and footwear stocks investment advice?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"No. This article is educational and uses publicly available data as of the 11 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Drug Ingredient, Vehicle and Footwear Stocks with a strong future roadmap: Neuland Laboratories, Force Motors and Bata India. Compare price, valuation, return on equity and revenue growth as of 11 November 2026.<\/p>\n","protected":false},"author":28,"featured_media":344735,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[845],"tags":[19524,15436,3803,22819,18535,8969,8590,22818,22817,22816],"class_list":["post-344736","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-best-stocks","tag-api-maker","tag-bata-india","tag-best-stocks","tag-commercial-vehicle-and-shoe-retail-stocks","tag-drug-ingredient","tag-force-motors","tag-neuland-laboratories","tag-pharma-ingredients","tag-tempo-traveller-and-shoe-brand-shares","tag-vehicle-and-footwear-stocks"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["344735"],"rank_math_title":["Pharma Ingredient, Vehicle and Footwear Stocks"],"rank_math_description":["Compare 3 drug ingredient, vehicle and footwear stocks with a strong future roadmap on CMP, market cap, P\/E, ROE and revenue growth. Data as of 11 Nov 2026."],"rank_math_focus_keyword":["drug ingredient, vehicle and footwear stocks"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/11\/3-pharma-ingredients-maker-utility-vehicles-maker-and-footwear-retailer-stocks.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/344736","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/28"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=344736"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/344736\/revisions"}],"predecessor-version":[{"id":344737,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/344736\/revisions\/344737"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/344735"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=344736"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=344736"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=344736"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}